Another study showed that the combination of topotecan and genistein exhibited better efficacy in LNCaP and PCa cells than either monotherapy, which was mediated by inducing apoptosis activated by caspase-3 and -9 and by ROS generation (Hörmann et al., 2012). This evidence concerns the gene CASP3 and posterior cortical atrophy.